A technology-enabled adherence enhancement system for people with bipolar disorder: Results from a feasibility and patient acceptance analysis

Patient Preference and Adherence

Volumn 9, Issue , 2015, Pages 753-758

  Sajatovic, Martha ^a   Davis, Michael S ^b   Cassidy, Kristin A ^a   Nestor, Joseph ^b   Sams, Johnny ^a   Fuentes Casiano, Edna ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MedicaSafe   (United States)

Author keywords

Adherence; Bipolar disorder; Compliance; Manic depressive disorder; Mood stabilizers

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; AUTOMATED PILL CAP WITH REMOTE MONITORING SENSOR; BIPOLAR DISORDER; CAUCASIAN; CLINICAL ARTICLE; FEASIBILITY STUDY; FEMALE; HEALTH PROGRAM; HUMAN; INTERNAL STATE SCALE; MALE; MEDICAL DEVICE; MEDICATION COMPLIANCE; MORISKY SCALE; MULTIMEDIA ADHERENCE ENHANCEMENT PROGRAM; PATIENT ATTITUDE; PATIENT MONITORING; PATIENT SATISFACTION; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; REIMBURSEMENT; SENSOR; TREATMENT KNOWLEDGE TEST;

EID: 84934979643     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S81724     Document Type: Article

References (29)

1. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(4 suppl):1–50.
2. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet. 1997;349(9063):1436–1442.
3. Begley CE, Annegers JF, Swann AC, et al. The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics. 2001;19(5 pt 1):483–495.
4. Keck PE Jr, Perlis RH, Otto MW, Carpenter D, Ross R, Docherty JP. The Expert Consensus Guidelines: Treatment of Bipolar Disorder; 2004. Postgraduate Medicine Report: Special Report: 1–120.
5. Goodwin GM, Young AH. The British association for psychopharmacology guidelines for treatment of bipolar disorder: a summary. J Psychopharmacol. 2003;17(4 suppl):3–6.
6. Yatham LN, Kennedy SH, O’Donovan C, et al. Canadian network for mood and anxiety treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord. 2005;7(suppl 3):5–69.
7. Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord. 2006;8(3):232–241.
8. Sajatovic M, Valenstein M, Blow F, Ganoczy D, Ignacio RV. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv. 2007;58(6):855–863.
9. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand. 2002;105(3):164–172.
10. Perlick DA, Rosenheck RA, Kaczynski R, Kozma L. Medication non-adherence in bipolar disorder: a patient-centered review of research findings. Clin Approaches in Bipolar Disord. 2004;3(2):56–64.
11. Volpp KG, Gurmankin Levy A, Asch DA, et al. A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol Biomarkers Prevent. 2006;15(1):12–18.
12. Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend. 2000;58:55–66.
13. Gine X, Karlan D, Zinman J. Put Your Money Where Your Butt is: A Commitment Savings Account for Smoking Cessation. Innovations for Poverty Action [Internet]; 2008 [cited March 1 2014]. Available from: http://documents.apec.umn.edu/DKarlanT&DSemSp08.pdf
14. Forness SR, Kavale KA, Blum IM, Llyod JW. Mage-analysis of meta-analysis: what works in special education and related services? Teach Except Child. 1997;29:4–9.
15. Schumacher JE, Milby JB, Wallace D, et al. Meta-analysis of day treatment and contingency-management dismantling research: Birmingham homeless cocaine studies (1990–2006). J Consult Clin Psychol. 2007;75(5):823–828.
16. Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006;101(2):192–203.
17. Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165(2):179–187.
18. Hulleman CS, Cordray DS. Moving from the lab to the field: the role of fidelity and achieved relative intervention strength. J Res Educ Eff. 2009;2:88–110.
19. Miklowitz DJ, Otto MW, Frank E, et al. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the systematic treatment enhancement program. Arch Gen Psychiatry. 2007;64(4):419–426.
20. Sauro J, Kindlund E. Using a single usability metric (SUM) to compare the usability of competing products. Paper presented at: Human Computer Interaction International Conference; July 22–27; 2005; Las Vegas, USA.
21. Wenze SJ, Armey MF, Miller IW. Feasibility and acceptability of a mobile intervention to improve treatment adherence in bipolar disorder: a pilot study. Behav Modif. 2014;38(4):497–515.
22. Burns MN, Begale M, Duffecy J, et al. Harnessing context sensing to develop a mobile intervention for depression. J Med Internet Res. 2011;13(3):e55.
23. Depp CA, Ceglowski J, Wang VC, et al. Augmenting psychoeducation with a mobile intervention for bipolar disorder: a randomized controlled trial. J Affect Disord. 2015;174:23–30.
24. Sajatovic M, Levin J, Tatsuoka C, et al. Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder. Bipolar Disord. 2012;14(3):291–300.
25. Sajatovic M, Levin J, Tatsuoka C, et al. Customized adherence enhancement for individuals with bipolar disorder receiving antipsychotic therapy. Psychiatr Serv. 2012;63(2):176–178.
26. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.
27. Bauer MS, Vojta C, Kinosian B, Altshuler L, Glick H. The internal state scale: replication of its discriminating abilities in a multisite, public sector sample. Bipolar Disord. 2000;2(4):340–346.
28. Bauer MS, Crits-Christoph P, Ball WA, et al. Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania. Arch Gen Psychiatry. 1991;48(9):807–812.
29. Baldessarini R, Henk H, Sklar A, Chang J, Leahy L. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatr Serv. 2008;59(10):1175–1183.